Emcure Pharma and Sanofi India announced that they entered into an exclusive distribution and promotion agreement for the latter's oral anti-diabetic products in India, effective immediately. Emcure ...

Benchmark indices Nifty and Sensex opened in the red on July 17, as investors remained cautious despite a strong close on Wall Street. Mixed cues from Asian markets and lingering worries over weak Q1 ...

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...